Skip to main content
Log in

Production of the antibiotic gallidermin by Staphylococcus gallinarum – development of a scale-up procedure

  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

A scale-up strategy into 200 l pilot-scale for the production of the antibiotic gallidermin by Staphylococcus gallinarum Tü 3928 was developed. Large-scale fermentations were simulated by consecutive liquid cultures of smaller scale. Afterwards, optimised cultivation conditions were transferred to pilot-scale. Best results were achieved by addition of Maltose during the late production phase leading to a final concentration of 330 mg gallidermin per litre. Compared to the concentrations found in a non-pulsed pilot-scale fermentations this is an increase of 20–30%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Clark GJ, Langley D, Bushell ME (1995) Oxygen limitation can induce microbial secondary metabolite formation: investigations with miniature electrodes in shaker and bioreactor culture. Microbiology 141: 663–669.

    Google Scholar 

  • Hörner T, Ungermann V, Zähner H, Fiedler H-P, Utz R, Kellner R, Jung G (1990) Comparative studies on the fermentative production of lantibiotics by staphylococci. Appl. Microbiol. Biotechnol. 32: 511–517.

    Google Scholar 

  • Hosobuchi M, Yoshikawa H (1999) Scale-up of microbial processes. In: Demain AL, Davies JE, eds. Manual of Industrial Microbiology and Biotechnology, 2nd edn. Washington: ASM Press, pp. 236–239.

    Google Scholar 

  • Humphrey A (1998) Shake flask to fermentor: what have we learned? Biotechnol. Prog. 14: 3–7.

    Google Scholar 

  • Ju L-K, Chase GG (1992) Improved scale-up strategies of bioreactors. Bioprocess Eng. 8: 49–53.

    Google Scholar 

  • Kellner R, Jung G, Hörner T, Zähner H, Schnell N, Entian KD, Götz F (1988) Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur. J. Biochem. 177: 53–59.

    Google Scholar 

  • Kempf M, Theobald U, Fiedler H-P (1997) Influence of dissolved O2 on the fermentative production of gallidermin by Staphylococcus gallinarum. Biotechnol. Lett. 19: 1063–1065.

    Google Scholar 

  • Kempf M, Theobald U, Fiedler H-P (1999a) Economic improvement of the fermentative production of gallidermin by Staphylococcus gallinarum. Biotechnol. Lett. 21: 663–667.

    Google Scholar 

  • Kempf M, Theobald U, Fiedler H-P (1999b) Correlation between the consumption of amino acids and the production of the antibiotic gallidermin by Staphylococcus gallinarum. Biotechnol. Lett. 21: 959–963.

    Google Scholar 

  • Reuss M, Bajpai R (1991) Stirred tank models. In: Rehm H-J and Reed G, eds. Biotechnology, Vol. 4, 2nd edn. Weinheim: VCH, pp. 299–348.

    Google Scholar 

  • Theobald U, Kempf M (1998) A novel tool for medium optimisation and characterization in the early stages of a metabolite production process. Biotechnol. Tech. 12: 893–897.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kempf, M., Theobald, U. & Fiedler, HP. Production of the antibiotic gallidermin by Staphylococcus gallinarum – development of a scale-up procedure. Biotechnology Letters 22, 123–128 (2000). https://doi.org/10.1023/A:1005667406165

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005667406165

Navigation